Latest News Archive

Please select Category, Year, and then Month to display items
Years
2019 2020 2021
Previous Archive
07 November 2019 | Story Leonie Bolleurs | Photo Leonie Bolleurs
Chemistry
Discussing progress in green energy and nuclear medicine during the recent ReMec2, were from the left: Dr Dumisani Kama (UFS), Prof Roger Alberto (University of Zurich), Prof Andreas Roodt (UFS), and Dr Orbett Alexander (UFS).

Scientists in South Africa and Switzerland, with a research collaboration of 20 years, are working together to make a difference. A major focus of their work is nuclear medicine and green energy. 

Since the end of October, 22 speakers from five countries met for five days at four different sites in South Africa to discuss their work during the second symposium on reaction mechanisms, better known as ReMec2. The Department of Chemistry at the University of the Free State (UFS) hosted this event. 

Considerable reduction of carbon dioxide

According to Prof Andreas Roodt, lead researcher from the UFS Department of Chemistry, ReMec2 focused mainly on two projects: nuclear medicine and an R8 million project titled: Solar Light-driven Homogeneous Catalysis for Greener Industrial Processes with H2 (hydrogen gas) as Energy Source and CO2 (carbon dioxide) as C1 Building Block. This is a sunlight-driven project in search of new catalysts, which are chemical compounds that make the reactions faster and more effective, but which are not consumed during the reaction. The aim is to provide greener industrial processes with hydrogen as energy source, and to reduce carbon dioxide in the environment.

This research, if applied, has the probability of preventing the release of more than 100 kg of harmful carbon dioxide for every one kg of hydrogen produced. “Together with the Swiss group, we are at that stage of the research where these compounds, with just one molecule of the catalyst, can make 80 000 hydrogen molecules (very clean energy, as hydrogen in a car's engine burns to clean water; not like gasoline that burns to harmful carbon dioxide),” Prof Roodt explains. 

The UFS and the research group from Prof Robert Alberto at the University of Zurich have been working together on this research for the past twenty years. According to Prof Roodt, they are studying complete reaction mechanisms, including the time profile of how the different chemical compounds are reacting with each other and not just the simple product analysis as studied by most groups in the world. 

International patent on nuclear medicine

In June 2019, they registered an international patent on nuclear medicine model compounds. The patent was granted. During ReMec2, a lecture was presented on this patent, according to which a compound with an imaging isotope [Tc-99m] that has its own ‘X-rays’, can shed light on an affected organ in the human body for doctors to see where medicine should be administered. The same compound also contains the medicine to treat the disease. 

The work of these scientists is 100% in line with South Africa’s National Development Plan and it supports the UFS Strategic Plan. “The programme also builds on students’ research and increases network and collaboration possibilities. We receive more international acknowledgement for our research efforts and compete with the best in the world. Our research is not necessarily about having the best equipment (although it is very important), but critically it is about the generation of innovative ideas,” says Prof Roodt. 

News Archive

Inaugural lecture: Prof Robert Bragg, Dept. of Microbial, Biochemical and Food Biotechnology
2006-05-17



Attending the inaugural lecture were in front from the left Prof Robert Bragg (lecturer at the Department of Microbial, Biochemical and Food Biotechnology) and Frederick Fourie (Rector and Vice-Chancellor).  At the back from the left were Prof James du Preez (Departmental Chairperson:  Department of Microbial, Biochemical and Food Biotechnology) and Prof Herman van Schalkwyk (Dean: Faculty of Natural and Agricultural Sciences). Photo: Stephen Collett
 

A summary of an inaugural lecture delivered by Prof Robert Bragg at the University of the Free State:

CONTROL OF INFECTIOUS AVIAN DISEASES – LESSONS FOR MAN?

Prof Robert R Bragg
Department of Microbial, Biochemical and Food Biotechnology
University of the Free State

“Many of the lessons learnt in disease control in poultry will have application on human medicine,” said Prof Robert Bragg, lecturer at the University of the Free State’s (UFS) Department of Microbial, Biochemical and Food Biotechnology during his inaugural lecture.

Prof Bragg said the development of vaccines remains the main stay of disease control in humans as well as in avian species.  Disease control can not rely on vaccination alone and other disease-control options must be examined.  

“With the increasing problems of antibiotic resistance, the use of disinfection and bio security are becoming more important,” he said.

“Avian influenza (AI) is an example of a disease which can spread from birds to humans.  Hopefully this virus will not develop human to human transmission,” said Prof Bragg.

According to Prof Bragg, South Africa is not on the migration route of water birds, which are the main transmitters of AI.  “This makes South Africa one of the countries less likely to get the disease,” he said.

If the AI virus does develop human to human transmission, it could make the 1918 flu pandemic pale into insignificance.  During the 1918 flu pandemic, the virus had a mortality rate of only 3%, yet more than 50 million people died.

Although the AI virus has not developed human-to-human transmission, all human cases have been related to direct contact with infected birds. The mortality rate in humans who have contracted this virus is 67%.

“Apart from the obvious fears for the human population, this virus is a very serious poultry pathogen and can cause 100% mortality in poultry populations.  Poultry meat and egg production is the staple protein source in most countries around the world. The virus is currently devastating the poultry industry world-wide,” said Prof Bragg.

Prof Bragg’s research activities on avian diseases started off with the investigation of diseases in poultry.  “The average life cycle of a broiler chicken is 42 days.  After this short time, they are slaughtered.  As a result of the short generation time in poultry, one can observe changes in microbial populations as a result of the use of vaccines, antibiotics and disinfectants,” said Prof Bragg.   

“Much of my research effort has been directed towards the control of infectious coryza in layers, which is caused by the bacterium Avibacterium paragallinarum.  This disease is a type of sinusitis in the layer chickens and can cause a drop in egg product of up to 40%,” said Prof Bragg.

The vaccines used around the world in an attempt to control this disease are all inactivated vaccines. One of the most important points is the selection of the correct strains of the bacterium to use in the vaccine.

Prof Bragg established that in South Africa, there are four different serovars of the bacterium and one of these, the serovar C-3 strain, was believed to be unique to Southern Africa. He also recently discovered this serovar for the first time in Israel, thus indicating that this serovar might have a wider distribution than originally believed.

Vaccines used in this country did not contain this serovar.  Prof Bragg established that the long term use of vaccines not containing the local South African strain resulted in a shift in the population distribution of the pathogen.

Prof Bragg’s research activities also include disease control in parrots and pigeons.   “One of the main research projects in my group is on the disease in parrots caused by the circovirus Beak and Feather Disease virus. This virus causes serious problems in the parrot breeding industry in this country. This virus is also threatening the highly endangered and endemic Cape Parrot,” said Prof Bragg.

Prof Bragg’s research group is currently working on the development of a DNA vaccine which will assist in the control of the disease, not only in the parrot breeding industry, but also to help the highly endangered Cape Parrot in its battle for survival.

“Not all of our research efforts are directed towards infectious coryza or the Beak and Feather Disease virus.  One of my Masters students is currently investigating the cell receptors involved in the binding of Newcastle Disease virus to cancerous cells and normal cells of humans. This work will also eventually lead to a possible treatment of cancer in humans and will assist with the development of a recombinant vaccine for Newcastle disease virus,” said Prof Bragg.

We are also currently investigating an “unknown” virus which causes disease problems in poultry in the Western Cape,” said Prof Bragg.
 
“Although disinfection has been extensively used in the poultry industry, it has only been done at the pre-placement stage. In other words, disinfectants are used before the birds are placed into the house. Once the birds are placed, all use of disinfectants stops,” said Prof Bragg.

“Disinfection and bio security can be seen as the ‘Cinderella’ of disease control in poultry.  This is also true for human medicine. One just has to look at the high numbers of people who die from hospital-acquired infections to realise that disinfection is not a concept which is really clear in human health care,” said Prof Bragg.

Much research has been done in the control of diseases through vaccination and through the use of antibiotics. “These pillars of disease control are, however, starting to crumble and more effort is needed on disinfection and bio security,” said Prof Bragg.

Prof Bragg has been working in close co-operation with a chemical manufacturing company in Stellenbosch to develop a unique disinfectant which his highly effective yet not toxic to the birds.

As a result of this unique product, he has developed the continual disinfection program for use in poultry. In this program the disinfectant is used throughout the production cycle of the birds. It is also used to ensure that there is excellent pre-placement disinfection.

“The program is extensively used for the control of infectious diseases in the parrot-breeding industry in South Africa and the product has been registered in 15 countries around the world with registration in the USA in the final process,” said Prof Bragg.

“Although the problem of plasmid mediated resistance to disinfectants is starting to rear its ugly head, this has allowed for the opening of a new research field which my group will hopefully exploit in the near future,” he said.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept